fda glp-1 safety alert october 2025 Safe Pharmacy | Foundayo, a pill for weight management, has been approved by @fda. The medication is a daily tablet with different dosage strengths FDA targets more online vendors

But there are clinical and commercial lanes open to competition, and no dearth of market hopefuls vying for a spot as the diabetes and obesity landscape expands

However, data to the contrary also exist and some small studies raised concerns that GLP1-RA use in CKD may be associated with more gastrointestinal side effects, hypoglycemic events, and loss of muscle mass 17,18

However, those with uncontrolled hyperthyroidism, recent thyroid surgery, thyroid cancer, or elevated calcitonin levels should avoid GLP-1 or discuss risks thoroughly with an endocrinologist before proceeding

[DOI] [PMC free article] [PubMed] [Google Scholar] 94.Rajasekeran H., Cherney D.Z., Lovshin J.A